Diffuse alveolar hemorrhage emerging one week after starting high-dose corticosteroid therapy for granulomatosis with polyangiitis (GPA) with systemic lupus erythematosus (SLE)

Intern Med. 2015;54(20):2681-6. doi: 10.2169/internalmedicine.54.5299. Epub 2015 Oct 15.

Abstract

A 69-year-old man was diagnosed with granulomatosis with polyangiitis (GPA) based on the presence of skin granuloma, refractory otitis media, renal insufficiency and myeloperoxidase-antineutrophil cytoplasmic antibody positivity and slight lung opacity. He was treated with high-dose corticosteroid therapy. Despite the initial improvement of his renal function and a decrease in his C-reactive protein level, he suffered from an alveolar hemorrhage one week after the start of corticosteroid therapy. An anti-dsDNA antibody test was positive and the patient had hypocomplementemia. Elements of both GPA and systemic lupus erythematosus were thought to have affected his clinical course.

Publication types

  • Case Reports

MeSH terms

  • Adrenal Cortex Hormones / adverse effects*
  • Adrenal Cortex Hormones / therapeutic use
  • Aged
  • C-Reactive Protein / analysis
  • Dose-Response Relationship, Drug
  • Granulomatosis with Polyangiitis / complications*
  • Granulomatosis with Polyangiitis / drug therapy*
  • Hemorrhage / chemically induced*
  • Humans
  • Kidney Function Tests
  • Lupus Erythematosus, Systemic / complications*
  • Male
  • Peroxidase
  • Pulmonary Alveoli*

Substances

  • Adrenal Cortex Hormones
  • C-Reactive Protein
  • Peroxidase